DEVELOPMENT OF ENHANCED HIV 1 PSEUDOVIRION VACCINES

$181,850R21FY2000AINIH

Vanderbilt University, Nashville TN

Investigators

Paul W. Spearman

Linked publications & trials

Paper 14554091 Paper 11878896 Paper 10906178

View original record on NIH RePORTER →

DEVELOPMENT OF ENHANCED HIV 1 PSEUDOVIRION VACCINES · GrantIndex